Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 9, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Atrial threshold variability: implications for automatic atrial stimulation algorithms.

Mauro Biffi1, Girolamo Spitali, Massimo Stefano Silvetti

  • 1Istituto di Cardiologia, Università di Bologna, Bologna, Italy. mbiffi@aosp.bo.it

Pacing and Clinical Electrophysiology : PACE
|December 12, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multisystemic Assessment in Andersen-Tawil Syndrome: Report of Eighteen Individuals.

Diagnostics (Basel, Switzerland)·2026
Same author

[Ventricular tachycardia and left bundle branch block after transcatheter aortic valve implantation: is the valve guilty forever or not?]

Giornale italiano di cardiologia (2006)·2026
Same author

Sinus Rhythm Propagation and Low-Voltage Bridge in Koch's Triangle: How They Relate in Cryoablation of Atrioventricular Nodal Reentry Tachycardia in Children.

Journal of clinical medicine·2026
Same author

Age-associated chemokine receptor expression profiles in human peripheral blood monocyte subsets predict cardiovascular disease risk.

Frontiers in immunology·2026
Same author

Management of patients with atrial tachycardia: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), and the Association for European Paediatric and Congenital Cardiology (AEPC).

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Prescription opioid use and opioid use disorder among older adults with HIV in the USA from 2008 to 2021: a retrospective repeated cross-sectional study.

The Lancet. Primary care·2025

This study evaluated the reliability of automatic atrial threshold measurement (ACM) in pacemakers over a one-year period. Researchers found that ACM successfully tracks threshold changes, allowing for optimized stimulation settings that maintain high capture rates. The findings suggest specific programming strategies based on patient heart rhythm characteristics to ensure effective long-term therapy.

Area of Science:

  • Cardiology and cardiac electrophysiology research
  • Atrial threshold variability and pacemaker optimization within clinical engineering

Background:

Clinicians currently lack clear guidelines for optimizing automatic atrial stimulation features in modern pacemakers. Prior research has shown that threshold fluctuations occur throughout the day, yet the long-term stability of these changes remains poorly defined. That uncertainty drove this investigation into how circadian patterns influence device performance. No prior work had resolved the specific programming requirements needed to maintain consistent cardiac capture. It was already known that manual measurements are labor-intensive and often infrequent in standard clinical practice. This gap motivated a deeper look at automated verification systems to improve patient outcomes. Researchers needed to determine if automated systems could reliably replace manual checks over extended periods. Establishing these parameters is necessary for advancing cardiac rhythm management technology.

Purpose Of The Study:

The researchers aimed to evaluate the long-term reliability of automatic atrial threshold measurement in patients with implanted pacemakers. They sought to determine if circadian fluctuations in stimulation requirements could be managed through automated device features. The team investigated which clinical factors predict successful threshold verification to guide future programming strategies. They intended to provide practical recommendations for clinicians to achieve daily verification and high capture effectiveness. The study addressed the challenge of maintaining consistent stimulation despite the dynamic nature of cardiac thresholds. By analyzing long-term data, the authors hoped to optimize device settings for individual patient profiles. They focused on identifying the best balance between measurement frequency and battery longevity. This work serves to clarify how automated algorithms can enhance the standard of care for patients requiring permanent pacing.

Keywords:
cardiac pacingarrhythmia managementclinical electrophysiologydevice optimization

Frequently Asked Questions

The researchers propose that automatic atrial threshold measurement (ACM) success is primarily hindered by atrioventricular block, high percentages of atrial pacing, and atrial fibrillation. These factors disrupt the device's ability to accurately detect the minimum voltage required for cardiac capture compared to patients without these conditions.

The study utilized the EnPulse pacemaker, which features the Search AV+ (SAV+) algorithm. This tool maximizes intrinsic conduction by extending the paced atrioventricular delay, thereby facilitating clearer detection of atrial thresholds compared to standard pacing modes.

The authors state that maximizing atrioventricular conduction is necessary to improve detection. By programming the paced atrioventricular delay to 600 ms, the device reduces ventricular pacing, which allows for more accurate threshold identification compared to shorter delay settings.

More Related Videos

Programmed Electrical Stimulation in Mice
07:29

Programmed Electrical Stimulation in Mice

Published on: May 26, 2010

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

Related Experiment Videos

Last Updated: Jul 9, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Programmed Electrical Stimulation in Mice
07:29

Programmed Electrical Stimulation in Mice

Published on: May 26, 2010

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

Main Methods:

The research team conducted a prospective observational study involving seventy-six patients implanted with specific cardiac devices. They programmed six daily attempts to verify stimulation levels throughout the follow-up duration. Investigators maximized intrinsic heart activity by adjusting the paced atrioventricular delay settings. During the initial month, they set this interval to 400 ms, increasing it to 600 ms for the remainder of the year. The team compared automated data against manual clinical checks to validate accuracy. They tracked success rates and identified clinical predictors associated with measurement failures. Statistical analysis included correlation coefficients to assess the agreement between different verification methods. This approach allowed for a comprehensive evaluation of long-term device performance in a real-world clinical setting.

Main Results:

The study achieved a median success rate of 77% for automated threshold measurements over a twelve-month period. Automated results showed high concordance with manual checks, yielding a Rho value of 0.82. Daily fluctuations in threshold remained below 0.5 V in over 94% of cases during the first trimester. This stability improved to over 99% in subsequent months and following device replacements. The system successfully performed measurements on 86% of all days. Programming the Search AV+ feature to 600 ms significantly reduced ventricular pacing in patients with normal conduction. This adjustment improved the device's ability to detect thresholds accurately. The findings confirm that the automated system maintains high reliability for long-term cardiac rhythm management.

Conclusions:

The authors propose that automatic atrial threshold measurement maintains high reliability throughout extended follow-up periods. Their findings suggest that daily verification is feasible for most patients when programmed correctly. The researchers recommend two daily measurements for individuals with normal conduction and low pacing requirements. They suggest increasing to three or four daily checks for patients with specific conduction delays or frequent arrhythmias. The study indicates that adapting stimulation outputs based on the first trimester of implantation enhances long-term capture safety. These results imply that personalized programming strategies improve the overall effectiveness of atrial stimulation. The team concludes that their approach achieves high capture rates while minimizing unnecessary battery consumption. Their work provides a framework for clinicians to refine device settings for individual patient needs.

The Search AV+ algorithm serves as the primary data-management component. It functions by extending the atrioventricular interval to promote intrinsic conduction, which is essential for the device to isolate and measure the atrial threshold without interference from ventricular pacing.

The researchers observed a strong correlation between automated and manual measurements, with a Rho value of 0.82. This measurement confirms that the automated system provides reliable data compared to traditional clinical assessments.

The authors suggest that clinicians should adapt stimulation outputs to threshold plus 1 V during the first trimester, and threshold plus 0.5 V thereafter. This strategy aims to ensure effective atrial stimulation exceeds 99.5% throughout the patient's follow-up.